Who owns TRAVERE THERAPEUTICS INC (TVTX?
- CUSIP Number: 89422gaa5
Tip: Access positions for across all investors
Analyze quarterly positions in Travere Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Travere Therapeutics stock
Who bought or sold TRAVERE THERAPEUTICS INC (TVTX this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Linden Advisors | 86M | $122M | -5% | Dec 2025 |
|
| Context Capital Management | 58M | $82M | 123853% | Dec 2025 |
|
| D. E. Shaw & Co | 38M | $55M | -12% | Dec 2025 |
|
| FMR | 30M | $43M | 705% | Dec 2025 |
|
| Millennium Management | 16M | $23M | 21% | Dec 2025 |
|
| Advent Capital Management | 14M | $20M | -30% | Dec 2025 |
|
| Tenor Capital Management | 14M | $20M | 100% | Dec 2025 |
|
| Lord, Abbett & Co | 14M | $19M | 10% | Dec 2025 |
|
| Affinity Asset Advisors | 7.0M | $10M | 0% | Dec 2025 |
|
| Shenkman Capital Management | 6.7M | $9.8B | 7% | Dec 2025 |
|
| Goldman Sachs Group | 5.9M | $8.4M | 266% | Dec 2025 |
|
| M&G | 5.1M | $7.3M | 100% | Dec 2025 |
|
| Point72 Asset Management | 4.0M | $5.7M | -60% | Dec 2025 |
|
| BlackRock | 3.7M | $5.2M | 16% | Dec 2025 |
|
| Polar Capital Holdings | 2.5M | $3.5M | -69% | Dec 2025 |
|
| Gabelli Funds | 2.4M | $3.4M | 100% | Dec 2025 |
|
| Kohlberg Kravis Roberts & Co | 2.0M | $2.8M | 0% | Dec 2025 |
|
| Agf Management | 1.1M | $1.5M | -88% | Dec 2025 |
|
| Capstone Investment Advisors | 1.0M | $1.4M | 100% | Dec 2025 |
|
| New York State Common Retirement Fund | 800k | $1.1M | -60% | Dec 2025 |
|
| GAMCO Asset Management | 250k | $352k | 100% | Dec 2025 |
|
| Barclays | 155k | $221k | 100% | Dec 2025 |
|
| Branch Banking & Trust Company | 41k | $58k | 0% | Dec 2025 |
|
| Goss Wealth Management | 21k | $30k | 100% | Dec 2025 |
|
| Wiley Bros.-aintree Capital | 16k | $23k | 0% | Dec 2025 |
|
| Leucadia National Corporation | 11k | $16k | 100% | Dec 2025 |
|
| Northwestern Mutual Wealth Management Company | 2.0k | $2.8k | 0% | Dec 2025 |
|
Who sold out of Travere Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Graham Capital Management | Sep 2025 | 22M | $25M |
| Oaktree Capital Management | Sep 2025 | 9.2M | $10M |
| Insigneo Advisory Services | Sep 2025 | 13k | $15k |
| Wealth Enhancement Advisory Services | Sep 2025 | 10k | $12k |